MX9603291A - Derivados de cetona de trifluormetilo diastomericamente puras como inhibidoras de elastasa de leucocitos humanos. - Google Patents

Derivados de cetona de trifluormetilo diastomericamente puras como inhibidoras de elastasa de leucocitos humanos.

Info

Publication number
MX9603291A
MX9603291A MX9603291A MX9603291A MX9603291A MX 9603291 A MX9603291 A MX 9603291A MX 9603291 A MX9603291 A MX 9603291A MX 9603291 A MX9603291 A MX 9603291A MX 9603291 A MX9603291 A MX 9603291A
Authority
MX
Mexico
Prior art keywords
inhibitors
solvates
human leukocyte
trifluoromhyl
kone
Prior art date
Application number
MX9603291A
Other languages
English (en)
Inventor
Stephen John Pegg
George Joseph Sependa
Elwyn Peter Davies
Chris Allan Veale
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421550A external-priority patent/GB9421550D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of MX9603291A publication Critical patent/MX9603291A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052Val-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

la presente invencion se refiere a formas cristalinas del compuesto (S)-l(S)-2-(4-metoxibenzamida)-3-metilbutirilo)-N- ((S)-2-metil-l-(trifluoroacetil)propil)pirridina-2 -carboximida (I) y sus solvatos cristalinos, que son inhibidores de la elastasa de leucocitos (HLE) también conocida como elastasa neutrofila humana (HNE), haciendolos utiles siempre de tal inhibicion se desee, así como para herramientas de investigacion el diagnostico farmacologico y estudios relacionados, y para tratamiento relacionados en mamíferos, en los cuales este aplicado la HLE. La invencion también incluye composiciones farmacéuticas que contiene las formas cristalinas y sus solvatos, procesos para preparar las formas y solvatos cristalinos e intermediarios utiles en la síntesis de las formas cristalinas y solvatos. (Ver Formula).
MX9603291A 1994-02-11 1995-02-07 Derivados de cetona de trifluormetilo diastomericamente puras como inhibidoras de elastasa de leucocitos humanos. MX9603291A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9402680A GB9402680D0 (en) 1994-02-11 1994-02-11 Pyrrolidine derivatives
GB9421550A GB9421550D0 (en) 1994-10-26 1994-10-26 Heterocyclic derivative
PCT/GB1995/000242 WO1995021855A1 (en) 1994-02-11 1995-02-07 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase

Publications (1)

Publication Number Publication Date
MX9603291A true MX9603291A (es) 1997-02-28

Family

ID=26304315

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9603291A MX9603291A (es) 1994-02-11 1995-02-07 Derivados de cetona de trifluormetilo diastomericamente puras como inhibidoras de elastasa de leucocitos humanos.

Country Status (20)

Country Link
US (3) US5739157A (es)
EP (1) EP0743953B1 (es)
JP (1) JP3416142B2 (es)
CN (1) CN1140455A (es)
AT (1) ATE174034T1 (es)
AU (1) AU692515B2 (es)
CA (1) CA2180006A1 (es)
DE (1) DE69506380T2 (es)
DK (1) DK0743953T3 (es)
ES (1) ES2125004T3 (es)
FI (1) FI963132A (es)
GB (1) GB9402680D0 (es)
HK (1) HK1011033A1 (es)
IL (1) IL112613A (es)
MX (1) MX9603291A (es)
NO (1) NO313882B1 (es)
NZ (1) NZ279265A (es)
TW (1) TW414801B (es)
WO (1) WO1995021855A1 (es)
YU (1) YU7195A (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
GB9502152D0 (en) * 1995-02-03 1995-03-29 Zeneca Ltd Proline derivatives
AU7261196A (en) * 1995-10-10 1997-04-30 Eli Lilly And Company N-{2-substituted-3-(2-aminoethyl)-1h-indol-5-yl}-amides: new 5-ht1f agonists
ATE261969T1 (de) * 1996-03-28 2004-04-15 Glaxo Group Ltd Pyrrolopyrrolone als inhibitoren von neutrophiler elastase
PE107899A1 (es) * 1997-09-09 1999-11-17 Glaxo Group Ltd Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
GB9719172D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9719187D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
CA2498052C (en) 2002-09-10 2011-05-17 Bayer Healthcare Ag Heterocyclic derivatives
WO2005080372A1 (en) 2004-02-19 2005-09-01 Bayer Healthcare Ag Dihydropyridinone derivatives
DE102005037791A1 (de) * 2005-08-10 2007-02-15 Ernst-Moritz-Arndt Universität Greifswald Verwendung von spezifischen Trifluormethylketonen zur Vorbeugung und Behandlung einer Pankreatitis
MX2009005252A (es) * 2006-11-17 2009-05-28 Abbott Lab Aminopirrolidinas como antagonistas del receptor de quimiocina.
CN103226756A (zh) * 2013-04-28 2013-07-31 文俊 工艺品生产过程的工艺制作及生产过程的记录方法和系统
CN114650819A (zh) 2019-09-17 2022-06-21 美莱奥生物制药第四有限公司 用于治疗移植物排斥、闭塞性细支气管炎综合征和移植物抗宿主病的阿维来司他
EP4252850A3 (en) 2020-04-16 2023-11-15 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
WO2023067103A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
US5194588A (en) * 1985-01-22 1993-03-16 Ici Americas Inc. Aminoalcohol intermediates for peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives

Also Published As

Publication number Publication date
GB9402680D0 (en) 1994-04-06
DE69506380D1 (de) 1999-01-14
JP3416142B2 (ja) 2003-06-16
FI963132A0 (fi) 1996-08-09
NZ279265A (en) 1998-01-26
WO1995021855A1 (en) 1995-08-17
CN1140455A (zh) 1997-01-15
ATE174034T1 (de) 1998-12-15
CA2180006A1 (en) 1995-08-17
EP0743953A1 (en) 1996-11-27
EP0743953B1 (en) 1998-12-02
ES2125004T3 (es) 1999-02-16
AU1583995A (en) 1995-08-29
FI963132A (fi) 1996-08-09
NO963329D0 (no) 1996-08-09
IL112613A0 (en) 1995-05-26
DK0743953T3 (da) 1999-08-16
AU692515B2 (en) 1998-06-11
NO313882B1 (no) 2002-12-16
US6037363A (en) 2000-03-14
US5739157A (en) 1998-04-14
JPH09508902A (ja) 1997-09-09
IL112613A (en) 2000-02-29
TW414801B (en) 2000-12-11
NO963329L (no) 1996-10-09
HK1011033A1 (en) 1999-07-02
YU7195A (sh) 1998-09-18
US5907043A (en) 1999-05-25
DE69506380T2 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
AU3959693A (en) Alpha-aminoboronic acid peptides and their use as elastase inhibitors
IL105425A0 (en) Heterocyclic ketones
TW262475B (en) Heterocyclic amides, intermediates and process for their preparation and pharmaceutical compositions containing them
MX9603291A (es) Derivados de cetona de trifluormetilo diastomericamente puras como inhibidoras de elastasa de leucocitos humanos.
IL102805A0 (en) Substituted heterocycles
GB9307555D0 (en) Heterocyclic compounds
NZ300256A (en) Fluorinated Val-Pro-Val derivatives, ketal forms, medicaments, reduced precursors, a 3-amino-1,1,1-trifluoro-2-pentanol precursor
GB9211783D0 (en) Amide derivatives
HU9403700D0 (en) Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors
AU622316B2 (en) Fluoro-amide derivatives
GB8910550D0 (en) Substituted amides

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees